PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.260
-0.030 (-2.33%)
At close: Sep 2, 2026, 4:00 PM EDT
1.228
-0.032 (-2.56%)
After-hours: Sep 2, 2026, 7:50 PM EDT
PMV Pharmaceuticals Employees
PMV Pharmaceuticals had 54 employees as of December 31, 2025. The number of employees increased by 7 or 14.89% compared to the previous year.
Employees
54
Change (1Y)
7
Growth (1Y)
14.89%
Revenue / Employee
n/a
Profits / Employee
-$1,392,963
Market Cap
67.36M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 54 | 7 | 14.89% |
| Dec 31, 2024 | 47 | -16 | -25.40% |
| Dec 31, 2023 | 63 | 1 | 1.61% |
| Dec 31, 2022 | 62 | 8 | 14.81% |
| Dec 31, 2021 | 54 | 10 | 22.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Alps Group | 93 |
| MindWalk Holdings | 77 |
| eXoZymes | 32 |
| Boundless Bio | 28 |
| INmune Bio | 21 |
| iBio, Inc. | 20 |
| Edesa Biotech | 17 |
| Serina Therapeutics | 16 |
PMVP News
- 1 day ago - PMV Pharmaceuticals 42M share Spot Secondary priced at $1.21 - TheFly
- 1 day ago - PMV Pharma Announces Pricing of Oversubscribed $50 Million Public Offering of Securities - GlobeNewsWire
- 2 days ago - PMV Pharmaceuticals announces updated ovarian cancer data from PYNNACLE trial - TheFly
- 2 days ago - PMV Pharmaceuticals announces common stock, warrants offering - TheFly
- 2 days ago - PMV Pharma Announces Proposed Public Offering of Securities - GlobeNewsWire
- 2 days ago - PMV Pharmaceuticals Announces Updated Promising Rezatapopt Monotherapy Interim Ovarian Cancer Data From PYNNACLE Phase 2 Pivotal Trial - GlobeNewsWire
- 17 days ago - PMV Pharmaceuticals reports Q2 EPS (34c), consensus (40c) - TheFly
- 19 days ago - PMV Pharmaceuticals Reports Second Quarter 2026 Financial Results and Corporate Highlights - GlobeNewsWire